Study aid, not legal advice. caselaw is not a law firm and does not provide legal advice or engage in the unauthorized practice of law (UPL). All briefs, outlines, and citation tools on these pages are educational summaries for law students; they are not a substitute for advice from a licensed attorney admitted in your jurisdiction. Bar-admission rules vary by state. For court filings or client matters, verify every authority against the official reporter and your court's local rules. Use of caselaw does not create an attorney-client relationship.
FIBROGEN, INC., Applicant v. AKEBIA THERAPEUTICS, INC., 2015 — 136 S. Ct. 1 · caselaw · US
Contracts · MBE-tested
FIBROGEN, INC., Applicant v. AKEBIA THERAPEUTICS, INC.
136 S. Ct. 1192 L. Ed. 2d 994·Supreme Court of the United States·2015
Brief incoming
Hand-reviewed Bluebook brief (procedural posture, facts, issue, holding, reasoning, dissent) ships once the AI generation pipeline runs through this case. Join the waitlist to get notified when 1L briefs go live.
Opinion
FIBROGEN, INC., Applicant
v.
AKEBIA THERAPEUTICS, INC.
No. 15A252.
Supreme Court of the United States
Aug. 31, 2015.
William M. Jay, Goodwin Procter LLP, Washington, DC, for Petitioner.
ORDER
[MAJORITY — ANTHONY M. KENNEDY, Associate Justice of the Supreme Court of the United States.]
ANTHONY M. KENNEDY, Associate Justice of the Supreme Court of the United States.
UPON CONSIDERATION of the application of counsel for the applicant,
IT IS ORDERED that the order of the United States District Court for the Northern District of California granting discovery is stayed pending further order of the undersigned or of the Court.